ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

H Zhou

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2018: 1 paper

Papers 1

SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer. Co-author DOI 10.1038/onc.2017.393 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jie Fu · 1 shared paper, 2018 · strength 0.08
- Paper SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer. DOI 10.1038/onc.2017.393 ↗
Jianhua Ling · 1 shared paper, 2018 · strength 0.08
- Paper SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer. DOI 10.1038/onc.2017.393 ↗
Xianjun Yu · 1 shared paper, 2018 · strength 0.08
- Paper SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer. DOI 10.1038/onc.2017.393 ↗
Paul J. Chiao · 1 shared paper, 2018 · strength 0.08
- Paper SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer. DOI 10.1038/onc.2017.393 ↗
Shunrong Ji · 1 shared paper, 2018 · strength 0.08
- Paper SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer. DOI 10.1038/onc.2017.393 ↗
Yi Qin · 1 shared paper, 2018 · strength 0.08
- Paper SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer. DOI 10.1038/onc.2017.393 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.